DOCSLIB.ORG

MINAX Contains the Active Ingredient Metoprolol Tartrate CONSUMER MEDICINE INFORMATION

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
MINAX Contains the Active Ingredient Metoprolol Tartrate CONSUMER MEDICINE INFORMATION MINAX contains the active ingredient metoprolol tartrate CONSUMER MEDICINE INFORMATION What is in this leaflet blood vessels in the body, as well as lung problems, or have had helping the heart to beat more them in the past This leaflet answers some common regularly. • You have a history of allergic questions about MINAX. It does not Your doctor will have explained why problems, including hayfever contain all of the available you are being treated with MINAX • You have low blood pressure information. and told you what dose to take. MINAX may be used either alone or • You have a very slow heartbeat It does not take the place of talking to (less than 45-50 beats/minute) your doctor or pharmacist. in combination with other medicines to treat your condition. • You have certain other heart All medicines have benefits and conditions risks. Your doctor has weighed the Ask your doctor if you have any risks of you taking MINAX against questions about why MINAX has • You have phaeochromocytoma the benefits they expect it will have been prescribed for you. (a rare tumour of the adrenal for you. Your doctor may have prescribed gland) which is not being MINAX for another reason. treated already with other If you have any concerns about medicines taking this medicine, talk to your Follow all directions given to you • You have a severe blood vessel doctor or pharmacist. by your doctor carefully. disorder causing poor Keep this leaflet with your They may differ from the circulation in the arms and legs medicine. information contained in this leaflet. • You are receiving/having You may need to read it again. MINAX is not addictive. emergency treatment for shock or severely low blood pressure. If you are not sure whether you should start taking this medicine, What MINAX is used Before you take talk to your doctor. for MINAX Do not take this medicine after the expiry date printed on the pack or MINAX belongs to a group of When you must not take it medicines called beta-blockers. if the packaging is torn or shows MINAX is used to: Do not take MINAX if: signs of tampering. · lower high blood pressure, also • You have any allergies to If it has expired or is damaged, return called hypertension metoprolol tartrate, the active it to your pharmacist for disposal. ingredient in MINAX, or any of · prevent angina (chest pain) Do not give MINAX to children. the ingredients listed at the end The safety and effectiveness of · treat or prevent heart attacks, or of this leaflet, or any other beta- MINAX in children has not been reduce your risk of heart blocker medicine. complications following a heart established. Some of the symptoms of an allergic attack reaction may include shortness of If you are not sure whether you · prevent migraine headaches. breath, wheezing or difficulty should start taking this medicine, talk to your doctor. It works by changing the body©s breathing; swelling of the face, lips, response to some nerve impulses, tongue or other parts of the body; Before you start to take it especially in the heart. rash, itching or hives on the skin or you may feel faint. As a result, it decreases the heart©s You must tell you doctor if you need for blood and oxygen and • You have asthma, wheezing, have any allergies to: therefore reduces the amount of work difficulty breathing or other the heart has to do. It also widens the MINAX 1 · Metoprolol tartrate or any of the · calcium channel blockers or They may differ from the ingredients listed at the end of calcium antagonists, medicines information contained in this leaflet. this leaflet. used to treat blood pressure and If you do not understand the · Any other medicine, including angina, for example verapamil instructions on the pack ask your other beta-blocker medicines and diltiazem doctor or pharmacist for help. · Any other substances, such as · medicines used to treat high foods, preservatives or dyes. blood pressure, for example How much to take clonidine, hydralazine, and For high blood pressure: Tell your doctor if you have, or prazosin have had, any medical conditions, The usual starting dose is one 50 mg · medicines used to treat abnormal especially the following: or 100 mg tablet once a day for one or irregular heartbeat, for week. · Asthma, wheezing, difficulty example amiodarone, breathing or other lung problems disopyramide and quinidine The dose is then usually increased to 50 mg or 100 mg once or twice daily. · Diabetes · medicines used to treat arthritis, · An overactive thyroid gland pain, or inflammation, for Your doctor may tell you to take a different amount of MINAX. · Liver problems example indometacin and ibuprofen Follow your doctor's instructions · Kidney problems · warfarin, a medicine used to carefully. · Certain types of angina prevent blood clots If you are taking other prescription · Any other heart problems · digoxin, a medicine used to treat medicines which lower blood · Phaeochromocytoma, a rare heart failure pressure, your doctor may need to tumour of the adrenal gland change the dose of them to obtain the · medicines used to treat diabetes best results for you. · Any blood vessel disorder · cimetidine, a medicine used to causing poor circulation in the For angina pectoris: treat stomach ulcers arms and legs. The usual dose is 50 mg or 100 mg · medicines used to treat bacterial Tell your doctor if you are taken two or three times a day. infections, for example rifampicin pregnant or plan to become After myocardial infarction (heart · medicines used to treat pregnant. attack): depression. Like most beta-blocker medicines, The usual dose is 100 mg taken twice · Monoamine-oxidase inhibitors MINAX is not recommended for use a day, often starting with a lower (MAOIs). during pregnancy. dose for 2 days. These medicines may be affected by Tell your doctor if you are For migraine prevention: breastfeeding or wish to MINAX or may affect how well it The usual dose is 50 mg to 75 mg breastfeed. works. You may need different amounts of your medicine, or you taken twice a day (100 to 150 mg a MINAX passes into breast milk, may need to take different medicines. day), taken in divided doses morning hence there is a possibility that the Your doctor will advise you. and evening. breastfed baby may be affected. Your doctor and pharmacist have Ask your doctor or pharmacist if If you have not told your doctor more information on medicines to be you are unsure of the correct dose about any of the above, tell them careful with or avoid while taking for you. before you start taking MINAX. MINAX. They will tell you exactly how much to take. Taking other medicines If you have not told your doctor about any of these things, tell them Tell your doctor or pharmacist if before you take any MINAX. How to take it you are taking any other Swallow the tablets with a glass of medicines, including any that you water. buy without a prescription from a MINAX tablets can be divided in pharmacy, supermarket or health How to take MINAX food shop. half along the breakline, if your doctor has prescribed half a tablet. Some medicines and MINAX may Follow all directions given to you interfere with each other. These by your doctor or pharmacist include: carefully. · other beta-blocker medicines, including beta-blocker eye drops MINAX 2 When to take it You may need urgent medical dropping too much. If you continue attention. to feel unwell, tell your doctor. Take your medicine at about the same time each day before or after If you take too much MINAX your If you are being treated for food. blood pressure may drop too far. You diabetes, make sure you check will feel faint or faint, and your heart your blood sugar level regularly Taking it at the same time each day rate will also slow down. You may and report any changes to your will have the best effect. It will also also have nausea, vomiting and doctor. help you remember when to take it. convulsions. In extreme cases, MINAX may affect how well your serious heart and lung problems may How long to take it diabetes is controlled. It may also occur. cover up some of the symptoms of Continue taking your medicine for low blood sugar (also called as long as your doctor tells you. hypoglycaemia) such as a fast This medicine helps to control your heartbeat. MINAX may increase the condition, but does not cure it. It is While you are taking time your body takes to recover from important to keep taking your MINAX low blood sugar. Your doctor may medicine even if you feel well. need to change your dose of diabetic DO NOT STOP TAKING MINAX Things you must do medicines, including insulin. TABLETS SUDDENLY. Visit your doctor regularly so they Before starting any new medicine, The dose needs to be reduced slowly can check on your progress. tell your doctor or pharmacist that you are taking MINAX. over 7 to 14 days to make sure that Elderly patients especially need to be your condition does not get worse. monitored to stop their blood Tell all the doctors, dentists and Your doctor will tell you how to pressure falling too far. pharmacists who are treating you gradually reduce the dose before that you are taking MINAX. stopping completely. If you become pregnant while taking MINAX, tell your doctor. Tell your surgeon, anaesthetist or dentist that you are taking MINAX If you have a severe allergic If you forget to take it if you plan to have surgery, reaction to foods, medicines or If it is almost time for your next including dental surgery, that insect stings, tell your doctor dose (within 6 hours), skip the dose needs a general anaesthetic.
Load more

Recommended publications
  • CORONARY ARTERY DISEASE Etiology and Pathophysiology
    806 Section 7 Problems of Oxygenation: Perfusion ing can be injured as a result of tobacco use, hyperlipidemia, hy- 493,623 pertension, diabetes, hyperhomocysteinemia, and infection (e.g., 500 433,825 Males Chlamydia pneumoniae, herpes) causing a local infl ammatory re- sponse3,4 (Fig. 34-2, A). 400 Females C-reactive protein (CRP), a nonspecifi c marker of infl amma- tion, is increased in many patients with CAD. Chronic exposure to 300 288,768 268,503 even minor elevations of CRP can trigger the rupture of plaques Cardiovascular System Cardiovascular and promote the oxidation of low-density lipoprotein (LDL) cho- 200 lesterol, leading to increased uptake by macrophages in the endo- 5,6 64,103 thelial lining. Deaths in thousands 69,257 41,877 100 60,713 Developmental Stages. CAD is a progressive disease that 34,301 38,948 takes many years to develop. When it becomes symptomatic, the 0 disease process is usually well advanced. The stages of development ABCDE ABDEF in atherosclerosis are (1) fatty streak, (2) fi brous plaque resulting from smooth muscle cell proliferation, and (3) complicated lesion. A Total CVD (Preliminary) D Chronic Lower Respiratory Diseases B Cancer E Diabetes Mellitus Fatty Streak. Fatty streaks, the earliest lesions of atherosclero- 2 C Accidents F Alzheimer’s Disease sis, are characterized by lipid-fi lled smooth muscle cells. As streaks of fat develop within the smooth muscle cells, a yellow FIG. 34-1 Leading causes of death for all men and women. CVD, Cardiovas- cular disease. tinge appears. Fatty streaks can be observed in the coronary arter- ies by age 15 and involve an increasing amount of surface area as the patient ages.
    [Show full text]
  • METOPROLOL IV MYLAN Metoprolol Tartrate
    METOPROLOL IV MYLAN metoprolol tartrate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about METOPROLOL IV MYLAN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you being given METOPROLOL IV MYLAN against the benefits they expect it will have for you. If you have any concerns about being given this medicine, ask your doctor, nurse or pharmacist. Keep this leaflet with the medicine. You may need to read it again. What METOPROLOL IV MYLAN is used for Your medicine contains metoprolol tartrate as the active ingredient. This medicine belongs to a group of medicines called beta-blockers. METOPROLOL IV MYLAN 1 Metoprolol tartrate is used to treat an irregular heartbeat, also known as arrhythmia, which means that there is a disturbance of the heart's normal rhythm or beat. Arrhythmias may be caused by numerous factors, including some heart diseases, an overactive thyroid gland or chemical imbalances. After a heart attack there is also a chance of developing an arrhythmia. Metoprolol tartrate helps to restore your heart beat to a more normal rate, particularly if it is beating very fast. Ask your doctor if you have any questions about why this medicine has been prescribed for you. Your doctor may have prescribed it for another reason. This medicine is not addictive. Before you are given METOPROLOL IV MYLAN When you must not be given it You should not be given METOPROLOL IV MYLAN if: • you have any allergies to metoprolol tartrate, any other beta-blocker medicine, any of the ingredients listed at the end of this leaflet.
    [Show full text]
  • Retinal Image Analysis and Diagnosis of Retinal Blood Vascular Diseases Using Deep Learning Model
    Retinal Image Analysis and Diagnosis of Retinal Blood Vascular Diseases using Deep Learning Model Bismita Choudhury (Student ID: 100063702) A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy (PhD) (Computer Science and Engineering) Faculty of Engineering, Computing, and Science Swinburne University of Technology Sarawak Campus May/2019 “Research is what I’m doing when I don’t know what I’m doing.” – Wernher von Braun THESIS – DOCTOR OF PHILOSOPHY (PHD) Abstract The retina is not only an important part of the visual system, but it also has the potential to indicate the general health of the other parts of the human body. In addition to the eye disease, various retinal abnormalities can be indicative of other health issues. Recent studies have show n that these retinal abnormalities associated with the blood vascular disease are predictive to several major diseases, viz., Diabetes, Cardiovascular diseases like Hypertension and Coronary heart disease, Kidney disease, and Stroke. Among the various blood vascular diseases, Diabetic Retinopathy (DR) and Retinal Vein Occlusion (RVO) are the two leading causes of blindness worldwide. The main causes for both of these sight-threatening retinal diseases are the age, obesity and sedentary lifestyle of people. As these factors are beyond controllable to avoid such diseases, therefore, it is particularly important to detect these retinal abnormalities as early as possible and prevent the visual imparity. The recent years have seen the increased interest in diagnosing various diseases through Computer Aided Diagnosis (CAD) of the digital images. In past decades, several such methods have been proposed for diagnosing DR.
    [Show full text]
  • Clinical Research on the Rehabilitation of Stroke Patients' Motor Ability
    2002. Vol. 3. No. 1. 107-119 Korean Journal of Oriental Medicine Original Article Clinical Research on the rehabilitation of Stroke patients’ motor ability Chang-Nam Ko, Sang-Kwan Moon, Ki-Ho Cho, Young-Suk Kim, Hyung-Sub Bae, Kyung-Sub Lee Department of Cardiovascular and Neurological diseases(Storke center) Kyunghee University, Seoul, Korea Abstract Background and Purpose: This clinical study investigated the effect of oriental medical treatment (herbal medicine, acupuncture & moxibustion therapy, physiotherapy, etc.) for the motor recovery improvement in stroke patients. The MBI (Modified Barthel Index) and NIHSS (National Institute of Health Stroke Scale) were used to evaluate the motor recovery in these patients. Methods: We selected the 151 stroke patients (79 male and 72 female) who visited Kang Nam Korean Hospital, Kyunghee University from June 1. 2000 to June 30. 2001 and investigated their characteristics, risk factors, past history, lesion area and size, symptoms, admission period and the period from onset to admission. We analyzed the MBI & NIHSS records to prove the efficacy of oriental medical treatment. Results and conclusions: Age distribution shows in 60s, 70s, 50s, 40s and 80s. The average age was 65.6±10.0. Gender ratio was 1.09:1(M:F). Lesion areas were mostly in the MCA (Middle Cerebral Artery), multifocal, brainstem and PCA (Posterior Cerebral Artery). Antecedent diseases of stroke patients were hypertension (78.4%), heart diseases, and diabetes mellitus, prior attacks. Symptoms of these patients are motor disturbance, verbal disturbance, swallowing disturbance and stool and urine disturbance. The mean admission period was 35.3±36.2 days. The significant period from onset to admission was 23.6 ±42.8 days.
    [Show full text]
  • BETALOC® TABLETS Metoprolol Tartrate
    BETALOC® TABLETS Metoprolol tartrate Consumer Medicine Information What is in this leaflet the heart has to do. It also widens the hives on the skin or you may feel blood vessels in the body, as well as faint. This leaflet answers some of the helping the heart to beat more • you have asthma, wheezing, common questions people ask about regularly. difficulty breathing or other BETALOC tablets. It does not Your doctor will have explained why lung problems, or have had contain all the information that is you are being treated with them in the past known about BETALOC. BETALOC and told you what dose • you have a history of allergic It does not take the place of talking to to take. problems, including hayfever your doctor or pharmacist. BETALOC may be used either alone • you have low blood pressure All medicines have risks and or in combination with other medicines to treat your condition. • you have a very slow heartbeat benefits. Your doctor will have (less than 45-50 beats/minute) weighed the risks of you taking Ask your doctor if you have any BETALOC against the benefits they questions about why BETALOC • you have certain other heart expect it will have for you. has been prescribed for you. conditions If you have any concerns about Your doctor may have prescribed this • you have phaeochromocytoma taking this medicine, ask your medicine for another reason. (a rare tumour of the adrenal doctor or pharmacist. gland) which is not being Follow all directions given to you treated already with other Keep this leaflet with the medicine.
    [Show full text]
  • Rare and Hereditary Causes of Stroke-A Literature Review Eyisi CS1*, Onwuekwe IO1, Eyisi IG2 and Ekenze O1
    Eyisi et al. Int J Neurodegener Dis 2018, 1:005 Volume 1 | Issue 1 Open Access International Journal of Neurodegenerative Disorders RESEARCH ARTICLE Rare and Hereditary Causes of Stroke-A Literature Review Eyisi CS1*, Onwuekwe IO1, Eyisi IG2 and Ekenze O1 1Neurology Unit, Department of Medicine, College of Medicine, University of Nigeria Teaching Hospital, Nigeria Check for 2Department of Community Medicine, College of Medicine, Chukwuemeka Odumegwu Ojukwu University, updates Nigeria *Corresponding author: Dr. Eyisi Chioma, Neurology Unit, Department of Medicine, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State, Nigeria, Tel: +2348168858498 brainstem stroke syndromes and herniation syndromes. Abstract Background: Rare and hereditary diseases are important Traditionally stokes are classified as ischemic or hem- in causing stroke in children, younger patients and women orrhagic, the former more common than the latter in a [1]. These diseases have a world-wide prevalence, howev- ratio of 6:1 [1]. Conventional risk factors for stroke oc- er they are not commonly diagnosed in Nigeria because of currence have also be described and grouped into mod- unavailability of gene mapping technologies. Notable ex- ceptions include Moyamoya disease which commonly occur ifiable and non-modifiable risk factors [1]. Modifiable in Asian populations and Chronic Myelogenous Leukemia risk factors include hypertension, Smoking, Lifestyle, Al- which causes stroke in the 7th and 8th decade, in contrast to cohol, High cholesterol, Atrial fibrillation, Obesity, Dia- other diseases that cause stroke in the 1st to 3rd decades [1]. betes, Severe carotid stenosis, Sleep apnea. Non-modi- Aim: The aim of this paper is to review several rare and fiable risk factors comprise of Male sex, African race and hereditary causes of stroke.
    [Show full text]
  • Sandoz Bisoprolol Tablets Con
    READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Sandoz Bisoprolol Tablets Bisoprolol fumarate 5 mg, 10 mg tablets Read this carefully before you start taking Sandoz Bisoprolol Tablets and each time you get a refill. This leaflet is a summary and will not tell you everything about this drug. Talk to your healthcare professional about your medical condition and treatment and ask if there is any new information about Sandoz Bisoprolol Tablets. What is Sandoz Bisoprolol Tablets used for? Sandoz Bisoprolol Tablets is used to treat hypertension (high blood pressure). How does Sandoz Bisoprolol Tablets work? Bisoprolol belongs to the group of drugs called "beta-blockers". Sandoz Bisoprolol Tablets decreases blood pressure and reduces how hard the heart has to work. What are the ingredients in Sandoz Bisoprolol Tablets? Medicinal ingredients: Bisoprolol fumarate Non-medicinal ingredients: calcium hydrogen phosphate, colloidal anhydrous silica, croscarmellose sodium, hypromellose, lactose monohydrate, macrogol (polyethylene glycol), maize starch (pregelatinised), magnesium stearate, microcrystalline cellulose, red ferric oxide (10 mg only), titanium dioxide and yellow ferric oxide (5 mg and 10 mg only). Sandoz Bisoprolol Tablets comes in the following dosage forms: 5 mg, 10 mg tablets Do not use Sandoz Bisoprolol Tablets if you: are allergic to bisoprolol, any of the non-medicinal ingredients or to another beta- blocker; have severe drops in blood pressure, dizziness, fast heartbeat, rapid and shallow breathing, cold clammy skin (signs of a heart disorder called cardiogenic shock); have a slow or irregular heartbeat or have been told you have heart block; have heart failure and your symptoms are getting worse.
    [Show full text]
  • Oxford Handbook of Clinical Haematology
    https://kat.cr/user/tahir99/ Haematological emergencies Septic shock/neutropenic fever E p636 Acute transfusion reactions E p638 Delayed transfusion reaction E p642 Post-transfusion purpura E p643 Hypercalcaemia E p644 Hyperviscosity E p646 Disseminated intravascular coagulation E p648 Overdosage of thrombolytic therapy E p651 Heparin overdosage E p652 Heparin-induced thrombocytopenia (HIT) E p654 Warfarin overdosage E p656 Massive blood transfusion E p658 Paraparesis/spinal collapse E p662 Leucostasis E p663 Thrombotic thrombocytopenic purpura E p664 Sickle crisis E p666 Tumour lysis syndrome (TLS) E p690 https://kat.cr/user/tahir99/ oxford medical publications Oxford Handbook of Clinical Haematology https://kat.cr/user/tahir99/ Published and forthcoming Oxford Handbooks Oxford Handbook for the Foundation Programme 4/e Oxford Handbook of Acute Medicine 3/e Oxford Handbook of Anaesthesia 2/e Oxford Handbook of Applied Dental Sciences Oxford Handbook of Cardiology 2/e Oxford Handbook of Clinical and Laboratory Investigation 2/e Oxford Handbook of Clinical Dentistry 6/e Oxford Handbook of Clinical Diagnosis 3/e Oxford Handbook of Clinical Examination and Practical Skills 2/e Oxford Handbook of Clinical Haematology 4/e Oxford Handbook of Clinical Immunology and Allergy 3/e Oxford Handbook of Clinical Medicine—Mini Edition 9/e Oxford Handbook of Clinical Medicine 9/e Oxford Handbook of Clinical Pharmacy Oxford Handbook of Clinical Rehabilitation 2/e Oxford Handbook of Clinical Specialties 9/e Oxford Handbook of Clinical Surgery 4/e Oxford
    [Show full text]
  • CIMS Scientific Outcome Book 2012
    Care Institute of Medical Sciences Outcomes 2012 Green Hospital C I M S NABL A premier multi-super specialty GREEN hospital What's Inside u Vision, Mission and Values ........................2 u Spine Surgery .......................................69 u Chairman's Letter ....................................3 u Urosurgery ...........................................72 u Board of Directors....................................5 u Onco Surgery ......................................74 u Accreditations ........................................6 u General Surgery ....................................77 u Abbreviations .........................................8 u Plastic Surgery ......................................78 u Mission 2013: Cancer and u Obstetrics and Gynecology .....................80 Radiotherapy Centre ..............................12 u ENT Surgery .........................................82 u Departmental Overview ..........................13 u Pain Management .................................83 u Cardiology ...........................................14 u Dentistry..............................................84 u Cardiac investigations ............................26 u Pathology ...........................................85 u Forefront in Cardiac Technology ...............27 u Radiology ............................................88 u Cardiac Rhythm Disorders ......................29 u Dialysis Center .....................................90 u Cardiac Surgery ..................................32 u Physiotherapy, Rehabilitation u Coronary
    [Show full text]
  • The Potential Antihypertensive and Antidiabetic
    The potential antihypertensive and antidiabetic activities of stevia in preventing chronic cardiovascular disease in rat models of hypertension and diabetes: Comparison to the calcium channel antagonist verapamil Saquiba Yesmine A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy School of Medical and Applied Sciences CQUniversity, Rockhampton, Queensland 2012 To my parents To my husband ii Acknowledgements This PhD journey has been made possible by the support and encouragement of many. I would like to thank them all for making this journey so rewarding and meaningful. Firstly, I would like to thank my supervisor Dr Andrew Fenning for his constant guidance, support and valuable comments during the course of this study. I thank him for his patience and spending many long hours in the ‘Fenning Lab’ with me during all my experiments. His encouragement and humour always made me feel comfortable and inspired me from the very first day. I thank my co-supervisor Dr. Fiona Coulson for her thoughtful advice, guidance and encouragement throughout the study. I gratefully acknowledge the support of an IDP (Australia) Post Graduate Research Scholarship that allowed me to undertake this study. I wish to thank my fellow PhD students Douglas Jackson, Rebecca Vella, Candice Pullen, Kylie Connolly, Alannah for their support and help in my experiments and sharing the fun time. I thank Maree Bennett and Laura Harbinson for their assistance during my experiments. I wish to acknowledge the assistance given by Damian Byrt, Graeme Boyle, Heather Smyth, Yvonne McDonald, Charmain Elder and all the technical staff of the Biomedical Sciences of CQUniversity with the spectrophotometer and in the chemistry lab.
    [Show full text]
  • Effectiveness of Self Instructional Module Regarding Emergency Management of Patient with Myocardial Infarction on Knowledge Among Staff Nurses
    IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-ISSN: 2320–1959.p- ISSN: 2320–1940 Volume 2, Issue 6 (Nov. – Dec. 2013), PP 14-19 www.iosrjournals.org Effectiveness of Self Instructional Module regarding Emergency Management of patient with Myocardial Infarction on Knowledge among Staff Nurses Binu Xavier Lecturer, SUM Nursing College,(SOA University) Kalinganagar K-8, Ghatikia, BBSR, Odisha,India Abstract: A quasi experimental study with one group pretest and posttest without control group design was undertaken in Vinayaka Missions Hospital, Salem to assess the effectiveness of self instructional module regarding emergency management of patient with myocardial infarction on knowledge among staff nurses Data was collected from 98 staff nurses selected by convenient sampling technique using closed ended questionnaire from 19.09.2009 to 02.10.2009. Data was analyzed by using descriptive and inferential statistics. Demographic characteristic reveals that the highest percentage (69%) of the staff nurses were in the age group of 21-25 years, were females (74%) were having B.Sc. nursing degree (80%). Highest percentage were having 3-4 yrs years of experience (69%), were working emergency unit (3%), ICU (20%), and general ward(29%) and other wards (48%) and did not attend in-service program (93%). The overall pretest mean score 22.06+1.92 which is 48% whereas in the post test the mean score (30.04+2.82) which is 65% of the total score with an overall difference of 17% of pretest score reveals good knowledge. Highly significant difference found between the pretest and posttest KS (P<0.01) but no significant association was found between the posttest KS when compared with the demographic variables of staff nurses (P<0.05).
    [Show full text]
  • Appendix Ch.8 (Annotated Version) Pathonyms
    Appendix Ch.8 (Annotated version) Pathonyms This is the annotated version of the list of pathonyms included in my Habilitationsschrift. Annotated means that I include the footnotes containing some important points (e.g. about ambiguities), explanations, and – most importantly – arguments concerning why I count expressions as pathonyms (with reference to the type of indicators found in the corpus – for the concept of indicators, see Chapter 8 in the book itself). The current version foregrounds the expressions themselves. I therefore do not present them in categories and I also omit frequencies. The pathonyms are therefore just listed in alphabetical order, just assigned to the two corpora. Self-help corpus [‘]atypical[’] symptom; [‘]bleeding[’] stroke; [‘]brain_stem[’] stroke; [‘]cryptogenic[’] stroke; [‘]lacunar[’] stroke; [‘]mini stroke[’]; [‘]silent[’] heart attack 1; [‘]stealth[’] heart attack 2; [o]edema; [vitamin] B_12 deficiency; [vitamin] B_6 deficiency; ‘bleed’ stroke; ‘block’ stroke; ‘brittle’ diabetes 3; ‘chemical’ diabetes 4; ‘dry’ stroke; ‘false-alarm’ symptom; ‘growing pains’; ‘Hollywood heart attack’ symptom; ‘morning after’ symptom; ‘office’ hypertension; ‘red flag’ symptom; “anything you say, doctor” syndrome; a fib; AAA; abdominal aneurysm; abdominal aortic aneurysm; abdominal cramp; abdominal cramping; abdominal discomfort; abdominal injury; abdominal obesity; abdominal pain; abdominal swelling; aberrations; abnormal abc1 gene; abnormal accumulation [e.g. of fluid]; abnormal activation of neurons; abnormal amount; abnormal
    [Show full text]